Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats

被引：0
|
作者：
Emilio Fernández-Varón
Carlos Cárceles-García
Juan Manuel Serrano-Rodríguez
Carlos M. Cárceles-Rodríguez
机构：
[1] University of Murcia,Department of Pharmacology, Faculty of Veterinary Medicine
[2] University of Cordoba,Department of Pharmacology, Toxicology and Legal and Forensic Medicine, Faculty of Veterinary Medicine
来源：
BMC Veterinary Research | / 12卷
关键词：
Ceftiofur; Pharmacokinetic/Pharmacodynamic; Long-acting formulation; Lactating goats;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Robenacoxib pharmacokinetics in goats (Capra hircus) following single oral, subcutaneous and intravenous administration
    Fadel, C.
    Lebkowska-Wieruszewska, Arturo
    Zizzadoro, C.
    Lisowski, A.
    Poapolathep, A.
    Giorgi, M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2023, 46 : 50 - 51
  • [42] Pharmacokinetics of levofloxacin after single intravenous, oral and subcutaneous administration to dogs
    Landoni, Maria Fabiana
    Albarellos, Gabriela Alejandra
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2019, 42 (02) : 171 - 178
  • [43] Pharmacokinetics (PK) and pharmacodynamics (PD) of palifermin (a r-huKGF molecule) in healthy volunteers after intravenous administration of single escalating doses up to 250 mcg/kg.
    Zia-Amirhosseini, P
    Salfi, M
    Leese, P
    Sullivan, JT
    BLOOD, 2004, 104 (11) : 341B - 342B
  • [44] Pharmacokinetics and milk penetration of enrofloxacin and its metabolite ciprofloxacin after subcutaneous administration to lactating goats
    Fernandez-Varon, E.
    Escudero, E.
    Marin, P.
    Titos, J. C.
    Espuny, A.
    Carceles, C. M.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2009, 32 : 196 - 197
  • [45] Pharmacokinetics (PK)-pharmacodynamics (PD) of intravenous busulfan (BU) in adult patients undergoing stem cell transplantaion.
    Hassoun, E
    Shimoni, A
    Nagler, A
    Halkin, H
    Almog, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P10 - P10
  • [46] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of ascending single doses of SRA-333 in healthy subjects
    Plotka, A
    Parks, V
    Raje, S
    Patat, A
    Chassard, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
  • [47] Pharmacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to dairy goats
    Courtin, F
    Craigmill, AL
    Wetzlich, SE
    Gustafson, CR
    Arndt, TS
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1997, 20 (05) : 368 - 373
  • [48] Population Pharmacokinetics (PK) of Tocilizumab Following Intravenous (IV) and Subcutaneous (SC) Administration to Patients with Rheumatoid Arthritis (RA)
    Gibiansky, Leonid
    Frey, Nicolas
    Hsu, Joy C.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S81 - S82
  • [49] Enoxaparin pharmacokinetics and Pharmacodynamics after intravenous bolus administration alone and at initiation of a subcutaneous dosing regimen
    Le Liboux, A
    Sanderink, GJ
    Grosjean, P
    Ozoux, ML
    Le Roux, Y
    Floch, A
    Montay, G
    Boutouyrie, B
    Rhodes, GR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 373A - 374A
  • [50] Pharmacokinetics (PK), pharmacodynamics (PD), and safety of AMG 162, a fully human monoclonal antibody to RANKL, following a single subcutaneous dose to healthy men aged 50 years and older
    Peterson, MC
    Ni, L
    Salfi, M
    Green, J
    Burns, D
    Gurrola, E
    Padhi, D
    BONE, 2005, 36 : S399 - S400
12345